Header Logo

Connection

ROBERT BRITTON to Humans

Back to Details
This is a "connection" page, showing publications ROBERT BRITTON has written about Humans.
ROBERT BRITTON
Connection Strength
0.423
Humans
  1. Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes. mSystems. 2025 Mar 18; 10(3):e0107524.
    View in: PubMed
    Score: 0.027
  2. Probiotics and the Microbiome-How Can We Help Patients Make Sense of Probiotics? Gastroenterology. 2021 01; 160(2):614-623.
    View in: PubMed
    Score: 0.020
  3. Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction. mSphere. 2020 07 29; 5(4).
    View in: PubMed
    Score: 0.019
  4. Probiotics: Promise, Evidence, and Hope. Gastroenterology. 2020 08; 159(2):409-413.
    View in: PubMed
    Score: 0.019
  5. Adaptation of the Gut Microbiota to Modern Dietary Sugars and Sweeteners. Adv Nutr. 2020 05 01; 11(3):616-629.
    View in: PubMed
    Score: 0.019
  6. Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease. Sci Rep. 2020 03 18; 10(1):4922.
    View in: PubMed
    Score: 0.019
  7. Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE. mSphere. 2020 02 12; 5(1).
    View in: PubMed
    Score: 0.019
  8. Scales of persistence: transmission and the microbiome. Curr Opin Microbiol. 2019 08; 50:42-49.
    View in: PubMed
    Score: 0.018
  9. The role of trehalose in the global spread of epidemic Clostridium difficile. Gut Microbes. 2019; 10(2):204-209.
    View in: PubMed
    Score: 0.017
  10. Genetic Tools for the Enhancement of Probiotic Properties. Microbiol Spectr. 2017 09; 5(5).
    View in: PubMed
    Score: 0.016
  11. Gut Microbiota and Bone Health. Adv Exp Med Biol. 2017; 1033:47-58.
    View in: PubMed
    Score: 0.015
  12. MiniBioReactor Arrays (MBRAs) as a Tool for Studying C. difficile Physiology in the Presence of a Complex Community. Methods Mol Biol. 2016; 1476:235-58.
    View in: PubMed
    Score: 0.014
  13. Cultivation of stable, reproducible microbial communities from different fecal donors using minibioreactor arrays (MBRAs). Microbiome. 2015 Sep 30; 3:42.
    View in: PubMed
    Score: 0.014
  14. Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome. 2015 Aug 20; 3:35.
    View in: PubMed
    Score: 0.014
  15. Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates. Infect Immun. 2014 Jul; 82(7):2815-25.
    View in: PubMed
    Score: 0.013
  16. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014 May; 146(6):1547-53.
    View in: PubMed
    Score: 0.012
  17. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 2012 Jul; 20(7):313-9.
    View in: PubMed
    Score: 0.011
  18. Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes. 2011 Mar-Apr; 2(2):69-79.
    View in: PubMed
    Score: 0.010
  19. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.007
  20. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
    View in: PubMed
    Score: 0.006
  21. A novel system to culture human intestinal organoids under physiological oxygen content to study microbial-host interaction. PLoS One. 2024; 19(7):e0300666.
    View in: PubMed
    Score: 0.006
  22. Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling. Gut Microbes. 2023 12; 15(2):2256043.
    View in: PubMed
    Score: 0.006
  23. Vaginal microbial dynamics and pathogen colonization in a humanized microbiota mouse model. NPJ Biofilms Microbiomes. 2023 Nov 20; 9(1):87.
    View in: PubMed
    Score: 0.006
  24. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
    View in: PubMed
    Score: 0.005
  25. Differentially Expressed Gene Pathways in the Conjunctiva of Sj?gren Syndrome Keratoconjunctivitis Sicca. Front Immunol. 2021; 12:702755.
    View in: PubMed
    Score: 0.005
  26. The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal. BMC Microbiol. 2021 05 24; 21(1):154.
    View in: PubMed
    Score: 0.005
  27. Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation. mBio. 2021 03 02; 12(2).
    View in: PubMed
    Score: 0.005
  28. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus. Gastroenterology. 2021 03; 160(4):1301-1314.e8.
    View in: PubMed
    Score: 0.005
  29. Rotavirus induces intercellular calcium waves through ADP signaling. Science. 2020 11 20; 370(6519).
    View in: PubMed
    Score: 0.005
  30. Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation. Gut Microbes. 2020 11 09; 12(1):1788898.
    View in: PubMed
    Score: 0.005
  31. Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain Axis. Cell Mol Gastroenterol Hepatol. 2021; 11(1):221-248.
    View in: PubMed
    Score: 0.005
  32. Enhancing responsiveness of human jejunal enteroids to host and microbial stimuli. J Physiol. 2020 08; 598(15):3085-3105.
    View in: PubMed
    Score: 0.005
  33. Microbiota in vitro modulated with polyphenols shows decreased colonization resistance against Clostridioides difficile but can neutralize cytotoxicity. Sci Rep. 2020 05 20; 10(1):8358.
    View in: PubMed
    Score: 0.005
  34. Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis. Am J Physiol Gastrointest Liver Physiol. 2020 05 01; 318(5):G870-G888.
    View in: PubMed
    Score: 0.005
  35. Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion. Cell Mol Gastroenterol Hepatol. 2019; 8(2):209-229.
    View in: PubMed
    Score: 0.004
  36. Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder. Neuron. 2019 01 16; 101(2):246-259.e6.
    View in: PubMed
    Score: 0.004
  37. Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Infect Immun. 2017 10; 85(10).
    View in: PubMed
    Score: 0.004
  38. Structural and functional insight into human O-GlcNAcase. Nat Chem Biol. 2017 06; 13(6):610-612.
    View in: PubMed
    Score: 0.004
  39. Mechanisms of cross-talk between the diet, the intestinal microbiome, and the undernourished host. Gut Microbes. 2017 03 04; 8(2):98-112.
    View in: PubMed
    Score: 0.004
  40. Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome. Curr Osteoporos Rep. 2015 Dec; 13(6):363-71.
    View in: PubMed
    Score: 0.004
  41. Intestinal microbial communities associated with acute enteric infections and disease recovery. Microbiome. 2015 Sep 22; 3:45.
    View in: PubMed
    Score: 0.003
  42. Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology (Reading). 2014 Apr; 160(Pt 4):671-681.
    View in: PubMed
    Score: 0.003
  43. Glycerol supplementation enhances L. reuteri's protective effect against S. Typhimurium colonization in a 3-D model of colonic epithelium. PLoS One. 2012; 7(5):e37116.
    View in: PubMed
    Score: 0.003
  44. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012; 7(2):e31951.
    View in: PubMed
    Score: 0.003
  45. Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl Environ Microbiol. 2008 Aug; 74(15):4645-9.
    View in: PubMed
    Score: 0.002
  46. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. Mol Cancer Ther. 2004 Oct; 3(10):1221-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.